Director's Dealing • Apr 22, 2020
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 4061K
Informa PLC
22 April 2020
Informa LEI: 5493006VM2LKUPSEDU20
Informa PLC Press Release
22 April 2020
Post Placing Director Shareholding Update
London: Informa PLC ("Informa" or "the Company"), the International Exhibitions, Events, Information Services and Advanced Learning Group, confirms that, following shareholder support for the proportionate participation of the Executive and Non-Executive Directors in the equity placing of 16 April 2020, the PLC Board Directors committed to purchase 80,398 shares in total, representing 0.03% of the placing.
The Directors combined proportionate participation includes the purchase of 40,199 shares issued on 20 April 2020, as detailed below. The other 40,199 shares will be issued and purchased after the General Meeting on 4 May 2020, subject to shareholder approval, with both tranches issued at the market-determined placing price of 400p per share.
| PDMR* | Proportionate Participation: Ordinary Shares issued on 20 April |
| David Flaschen | 700 |
| Derek Mapp | 17,362 |
| Gareth Bullock | 1,358 |
| Gareth Wright | 3,633 |
| Gill Whitehead | 625 |
| Helen Owers | 1,250 |
| John Rishton | 1,516 |
| Mary McDowell | 630 |
| Stephen A. Carter | 12,500 |
| Stephen Davidson | 625 |
*A summary of the full shareholding of all Executive and Non-Executive Directors is contained in the Annual Report & Accounts
| Enquiries | |
| Informa PLC Rupert Hopley, Company Secretary |
+44 (0)20 7017 5000 |
Informa is a leading international Exhibitions, Events, Information Services and Scholarly Publishing Group. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHKZGZDKMVGGZM
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.